DOJ announces nationwide takedown in $6.5 billion health care fraud
The Justice Department’s 2026 National Health Care Fraud Takedown charged 455 defendants across 45 states and territories. This explainer looks at the allegations, the legal context, and what patients, providers, and families may want to keep in mind.
Flat vector illustration of a DOJ health care fraud takedown with medical billing, enforcement, and multi-state investigation elements for health care fraud and DOJ takedown coverage.
Images
Videos
Publish Date (Social)
Scheduled (Social)
Images Posted (Social)
Videos Posted (Social)
Featured
Created time
Jun 24, 2026 10:51 PM
Sub-item
Authors
CTA Practice Area (Social)
TikTok Failed (Social)
Videos Post Links (Social)
TikTok Post Links (Social)
Images Post IDs (Social)
YT Post ID
Video Pending Manual (Social)
TikTok Posted (Social)
TikTok Post IDs (Social)
Video Cover (Social)
Images Post Links (Social)
First Comment (Social)
Videos Failed (Social)
YT Embedded
Images Delete (Social)
Videos Delete (Social)
Carousel Video URL (Social)
The Justice Department said on June 23, 2026 that it charged 455 defendants across 45 states and territories and 56 federal districts in the latest National Health Care Fraud Takedown, alleging more than $6.5 billion in false claims tied to health care and opioid-related schemes. According to the government’s 2026 National Health Care Fraud Takedown announcement, the cases include 90 doctors and other licensed medical professionals, along with allegations involving telemedicine, opioid diversion, Medicaid fraud, and bogus behavioral health and substance use treatment billing.
Federal officials also said the sweep involved roughly $182 million in seized assets, including cash, luxury vehicles, jewelry, and other property, and described the operation as one of the largest health care fraud crackdowns to date. HHS-OIG’s enforcement summary for the 2026 takedown states that the coordinated action also included participation from 50 state Medicaid Fraud Control Units, the most in department history.
Background On The Takedown
Health care fraud “takedowns” are coordinated national enforcement pushes that bundle criminal charges, civil complaints, settlements, administrative actions, and provider exclusions into one large public announcement. In plain terms, the government uses these events to show where it believes fraud is happening, how broad the conduct may be, and which sectors are drawing the most scrutiny.
This year’s nationwide fraud enforcement action appears especially broad. The Justice Department said the charged conduct spans false billing, kickbacks, unnecessary testing, prescription drug diversion, and schemes aimed at Medicare, Medicaid, and other insurers. The department also said the operation included international cooperation, with defendants apprehended or returned from Cyprus, Estonia, and the Philippines as part of related fraud matters in the broader enforcement push.
The government’s description of patient harm stands out here. In the Justice Department’s June 23 release, officials said the alleged schemes involved “significant patient harm, including death.” That language often signals that prosecutors may be focusing not only on billing irregularities, but also on medically unnecessary treatment, unlawful prescribing, and situations where alleged fraud may have affected actual care decisions.
According to AP, one of the highlighted cases involves an $89 million cardiovascular screening scheme in Florida, where a doctor is accused of billing insurers for allegedly unnecessary tests for student-athletes and certifying results as normal without personally reviewing them. AP reported that prosecutors allege one patient later died after significant heart problems were not detected.
Why This Enforcement Action Matters
For non-lawyers, a headline about “455 defendants” can feel abstract. But enforcement actions like this often matter far beyond the criminal docket.
Licensed Professionals Are A Major Focus
The DOJ said 90 charged defendants were doctors or other licensed medical professionals. That detail may matter because prosecutors often view licensed providers differently from outside marketers or billing companies. A medical license can carry independent duties tied to prescribing, supervision, medical necessity, documentation, and patient safety. When criminal charges overlap with those duties, the consequences can expand beyond court proceedings into licensing boards, exclusion lists, DEA registration issues, and payer enrollment problems.
The government also said the takedown included 928 DEA administrative cases seeking to revoke authority to handle or prescribe controlled substances since October 1, 2025, along with more than 1,400 provider exclusions and CMS payment suspensions and billing privilege revocations affecting thousands of providers in related administrative actions. Those figures appear in the DOJ’s summary of the coordinated enforcement effort and suggest that the fallout may extend well beyond the criminal indictments themselves.
Telemedicine And Behavioral Health Remain Under Intense Scrutiny
The takedown also highlights sectors that federal investigators have been revisiting for several years: telemedicine, durable medical equipment, substance use treatment, and behavioral health billing. HHS-OIG’s 2026 takedown page and the DOJ release both frame the cases as part of a broader strategy that uses data analytics to identify patterns in claims, prescribing, and reimbursement.
That may matter for legitimate providers too. Even businesses that view themselves as compliant may find that aggressive marketing arrangements, outsourced billing, loosely supervised telehealth models, or referral relationships draw attention if claims patterns resemble previously charged schemes. In general terms, this kind of takedown can reshape how payers, regulators, and prosecutors look at entire service lines.
Medicaid Fraud Is Getting More Visibility
The Justice Department’s release says this year produced record Medicaid fraud charges and the largest number of states participating in takedown history. That is a notable shift in emphasis. Medicare fraud has long drawn headlines, but the state-by-state Medicaid component may signal a more integrated federal-state approach, especially where transportation billing, community-based services, addiction treatment, or youth services are involved.
For providers and organizations working in Medicaid-heavy areas, that trend may mean closer review of licensing, service documentation, staffing credentials, prior authorization practices, and whether billed services were actually rendered as claimed.
What It May Mean For Patients, Providers, And Families
For patients and families, this kind of announcement can raise uncomfortable questions: Was a procedure really necessary? Were addiction treatment services real? Did a provider bill for care that never happened? If a loved one was harmed, was it negligence, fraud, or both?
Those questions matter because fraud investigations and civil injury claims are not the same thing, even though they can overlap. A criminal charge focuses on what the government alleges happened. A civil case may focus on financial loss, wrongful death, malpractice, kickbacks, consumer protection claims, or insurance issues. In some situations, the same underlying conduct can trigger several different legal paths at once.
For health care practices, executives, and licensed clinicians, the stakes can move quickly. A criminal complaint or indictment may be only the first layer. Many matters also involve subpoenas, search warrants, parallel civil investigations, suspension of billing privileges, repayment demands, exclusion risk, and professional licensing consequences. Some people learn they are involved only after bank accounts are frozen, records are seized, or business relationships begin to unravel.
That broader pattern is one reason these stories tend to resonate beyond the defendants named in the press release. As we noted in earlier coverage of this year’s broader fraud push, enforcement often expands outward from a single billing practice or referral network into marketers, owners, prescribing professionals, management companies, and affiliated vendors.
What Affected Parties Might Consider
People reading this news from close range may fall into very different groups: patients who suspect fake billing, families worried about treatment-related harm, clinicians facing inquiries, or owners trying to understand whether their organization is part of a larger probe.
In general terms, documentation often becomes central very fast. That can include billing records, explanation-of-benefits forms, patient charts, contracts, referral arrangements, prescribing logs, internal messages, and notices from insurers or regulators. An attorney might help determine whether a situation looks like a billing dispute, a civil False Claims Act exposure, a licensing problem, a criminal investigation, or some combination of those issues.
Patients and families may also want to consider that a public DOJ announcement does not automatically identify every person or company potentially affected by the alleged conduct. Sometimes the public release highlights examples while related civil, administrative, or state matters continue developing more quietly.
For licensed professionals and businesses, early legal guidance can matter even before charges are filed. A subpoena, audit letter, suspension notice, or contact from investigators may raise very different risks depending on the facts, the provider’s role, and whether the issue involves federal programs, controlled substances, or alleged patient harm. In situations like these, many people look for attorneys with documented experience in health care fraud defense, regulatory investigations, False Claims Act matters, professional licensing issues, or civil claims tied to medical billing and treatment practices.
Visit ReferU.AI to get matched with an attorney who has demonstrable experience in cases like yours — for free.